Early or Delayed Intervention of Brain Radiotherapy Combined With Almonertinib in EGFR Mutated NSCLC With Brain Metastases

Abroad (travel likely)RecruitingPHASE3

Conditions

Brain Metastases · Radiotherapy · EGFR Activating Mutation

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Sun-Yat-Sen university, Guangdong, Guangzhou, China
Contact: Study coordinator (Likun Chen) · chenlk@sysucc.org.cn · 13798019964

Study leads

Likun Chen
Principal Investigator
sunyat-sen university cancer center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

a Feasibility Study of iHD-SRT for BM

Brain Metastases, Adult · Stereotactic Radiotherapy

Abroad (travel likely)Recruiting

Shanghai, China

Hippocampus-Protective Radiotherapy Combined With Osimertinib for Symptomatic Brain Metastases in EGFR-Mutated Lung Cancer

Naive Advanced Non-small Cell Lung Cancer With EGFR-sensitive Mutations (EGFR Exon 19 Deletion and Exon 21 L858R Mutation) and Symptomatic Brain Metastases

Abroad (travel likely)RecruitingPHASE2

Tianjin, China

The CyberChallenge Trial How Much is Too Much - What is the Role of Cyberknife Radiosurgery in Patients With Multiple Brain Metastases?

Brain Metastases · Nsclc

Abroad (travel likely)Recruiting

Heidelberg, Germany

Corticodependent or Corticoresistant Brain Radionecrosis After Radiotherapy for Brain Metastases

Radionecrosis of Brain · Brain Metastases

Abroad (travel likely)RecruitingPHASE3

Brest, France · Caen, France